Gordon Naylor
President, Seqirus
Board of Management
CSL Behring
Germany
Biography
Val Romberg is responsible for CSL Behring’s state-of-the-art global manufacturing and plasma collection operations with sites in Germany, Australia, Switzerland and the USA where the company’s lifesaving biotherapies are produced. He is also accountable for Planning.Mr. Romberg has more than 30 years of experience in the pharmaceutical industry. In 1998 he joined Centeon, a predecessor company of CSL Behring, where he has held a broad range of positions. These include project management in King of Prussia, USA, where he was involved in the development of recombinant and plasma-derived products.Mr. Romberg has more than 30 years of experience in the pharmaceutical industry. In 1998 he joined Centeon, a predecessor company of CSL Behring, where he has held a broad range of positions. These include project management in King of Prussia, USA, where he was involved in the development of recombinant and plasma-derived products.When R&D was integrated into a single global operation in 2011, Mr. Romberg assumed the role of Senior Vice President, Plasma Product R&D. During his R&D tenure, CSL Behring had more than 25 product or indication approvals in the USA, Europe and Japan.
Research Interest
chemistry
